News

Yahoo Finance4y
Mustang Bio and City of Hope Announce First Patient Dosed in Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors - Yahoo Finance
All subjects enrolled in the Phase 1 single-center, two-arm clinical trial will undergo surgery for the placement of an intraventricular (ICV) Rickham catheter for CAR T cell delivery.
The New England Journal of Medicine8y
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy | NEJM - New England Journal of Medicine
Panel A shows an overview of intraventricular delivery (through a Rickham catheter device) of 10 cycles of IL13BBζ–CAR T cells into the right lateral ventricle (red arrow) from day 112 to day ...
Yahoo Finance4y
Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors - Yahoo Finance
Trial underway at City of Hope to evaluate safety and feasibility of administering therapy in patients with brain tumors such as glioblastoma, ependymoma or medulloblastomaWORCESTER, Mass., Dec ...
Nasdaq4y
Mustang Bio and City of Hope Announce First Patient Dosed in Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors - Nasdaq
First dose occurred in trial underway at City of Hope to evaluate safety and feasibility of administering therapy in patients with brain tumors such as glioblastoma, ependymoma or medulloblastoma ...
Nasdaq4y
Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors - Nasdaq
Trial underway at City of Hope to evaluate safety and feasibility of administering therapy in patients with brain tumors such as glioblastoma, ependymoma or medulloblastoma WORCESTER, Mass., Dec ...